DJIA 17,131.86 47.37 0.28%
NASDAQ 4,838.64 8.17 0.17%
S&P 500 2,017.46 2.57 0.13%
market minute promo

Exelixis (NASDAQ: EXEL)

5.78 -0.21 (-3.43%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

EXEL $5.78 -3.43%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $6.00
Previous Close $5.99
Daily Range $5.75 - $6.00
52-Week Range $1.26 - $6.81
Market Cap $1.3B
P/E Ratio -5.93
Dividend (Yield) $0.00 (0.0%)
Volume 3,322,196
Average Daily Volume 6,031,650
Current FY EPS -$0.81




Drug Makers

Exelixis (EXEL) Description

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases. Website:

News & Commentary

How Much Could Exelixis Really Be Worth?

One shareholder takes a stab at adding up the individual components of Exelixis' product portfolio and pipeline to estimate its fair value.

Roche (RHHBY) Reports Positive Data on Skin Cancer Drugs

Morning Market Gainers

Benzinga's Top #PreMarket Gainers

Kidney Cancer Drug Boxing Match

Bristol-Myers Squibb and Exelixis slug it out against Novartis.

10 Best NASDAQ Biotech Stock in the Third Quarter

Don't Panic! These 3 Beaten Down Biotech Stocks Are Now Great Buys

Biotech stocks have gotten pummeled in September -- and these three small-cap biotech stocks may now be too cheap too ignore.

Morning Market Losers

Benzinga's Top #PreMarket Losers

ECC - Cometriq Plays Wallflower As Opdivo's Dance Card Fills

See More EXEL News...

EXEL's Top Competitors

EXEL $5.78 (-3.43%)
Current stock: EXEL
TMO $125.90 (-0.49%)
Current stock: TMO
ILMN $146.51 (-0.85%)
Current stock: ILMN
WAT $120.59 (-0.27%)
Current stock: WAT